Sneha Girap (Editor)

Mark Fishman

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Name
  
Mark Fishman

Fields
  
Medicine, Cardiology




Institutions
  
Novartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School

Alma mater
  
Yale College, Harvard Medical School

Known for
  
pioneering Zebrafish research in cardiology

Notable awards
  
Institute of Medicine member, Fellow of the American Academy of Arts and Sciences

Education
  
Yale College, Harvard Medical School

Residence
  
United States of America

Rabbi mark fishman sex trafficking and the synagogue raising the engagement of our young adults


Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous President of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of Novartis Pharmaceuticals.

Contents

Mark Fishman Trading Spaces HMS

Fishman was appointed President of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort. He is the author of over 100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.

Mark Fishman Dr Mark Fishman Dynalite

Innovative drug discovery speeds new treatments to patients


Education

Mark Fishman Novartis Science on Twitter NIBR President Mark Fishman speaks

  • B.A. Yale College, 1972
  • M.D. Harvard Medical School, 1976
  • Career

    Mark Fishman Working Group A Vision and Pathway for NIH

    He was previously a Professor of Medicine at Harvard Medical School, Chief of Cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.

    Mark Fishman Fishman Novartis posting good results The Boston Globe

    After being the head of Novartis for 13 years, he has decided to retire in 2016.

    References

    Mark Fishman Wikipedia